| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 25.052 | 77.057 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 25.052 | 77.057 | 0 | 0 | 0 | 1.317 | 0 | 0 |
| Total Expenses - EUR | - | - | 13.110 | 39.385 | 0 | 11 | 5 | 1.180 | 90 | 10.142 |
| Gross Profit/Loss - EUR | - | - | 11.942 | 37.672 | 0 | -11 | -5 | 137 | -90 | -10.142 |
| Net Profit/Loss - EUR | - | - | 11.191 | 35.361 | 0 | -11 | -5 | 97 | -90 | -10.142 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vianando Sanomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 26.177 | 74.228 | 72.790 | 71.179 | 69.584 | 68.620 | 48.066 | 0 |
| Inventories | - | - | 1.628 | 600 | 589 | 577 | 565 | 0 | 0 | 0 |
| Receivables | - | - | 22.444 | 73.560 | 72.135 | 70.536 | 68.955 | 68.620 | 40.433 | 0 |
| Cash | - | - | 2.105 | 68 | 67 | 65 | 64 | 0 | 7.634 | 0 |
| Shareholders Funds | - | - | 11.235 | 46.389 | 45.491 | 44.618 | 43.623 | 43.856 | 43.633 | -10.094 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 14.956 | 27.839 | 27.299 | 26.562 | 25.961 | 24.764 | 4.433 | 10.094 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Vianando Sanomed Srl